To further explore the role of nucleocytoplasmic transport in MYC-driven cancer, we examined the effect of Xpo1 inhibition by Selinexor in a primary transgenic mouse model of HCC (LAP-tTA/tet-O-MYC/FVB/NJ)13. The gene discussed is XPO1; the disease is hepatocellular carcinoma.